Economic Outcome Analysis for BRAF Melanoma Anti-CD4+PD-1, & Anti-PD-1 both followed by BRAF-MEK

Economic Outcome Analysis for BRAF Melanoma Anti-CD4+PD-1, & Anti-PD-1 both followed by BRAF-MEK

User Photo
Annual-Meeting

2 years
112 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Ahmad Tarhini, MD, PhD, Cleveland Clinic Main Campus, shares Economic Outcome Analysis for BRAF Melanoma Anti-CD4+PD-1, & Anti-PD-1 both followed by BRAF-MEK at Annual Meeting 2018
Up Next Autoplay
>